Inhalation Sciences: Continued High Activity in the IRS Segment
Research Note
2022-03-18
11:00
Redeye endorses ISAB signing yet another IRS contract worth around SEK 773,000 (EUR 74,000). The contract is for a research project with a leading Swiss developer of inhaled generics. We are encouraged by the continued high activity in the IRS segment and retain our long-term positive view of ISAB.
Erik Nordström
Disclosures and disclaimers